Nobel H, Ofer J, Borenstein S, Limon D, Gal O, Laviv Y
J Neurooncol. 2025; .
PMID: 40072807
DOI: 10.1007/s11060-025-04979-1.
Kato T, Hasegawa T, Kuwabara K, Ohno M, Kuramitsu S, Naito T
J Neurosurg Case Lessons. 2025; 9(7).
PMID: 39961102
PMC: 11833232.
DOI: 10.3171/CASE24737.
Cozzi F, Mayrand R, Wan Y, Price S
J Neuroimaging. 2024; 35(1):e13251.
PMID: 39648937
PMC: 11626419.
DOI: 10.1111/jon.13251.
Hautiere M, Vivier D, Dorval P, Pineau D, Kereselidze D, Denis C
Theranostics. 2024; 14(16):6268-6280.
PMID: 39431005
PMC: 11488107.
DOI: 10.7150/thno.98163.
Sahu A, Mathew R, Ashtekar R, Dasgupta A, Puranik A, Mahajan A
Front Nucl Med. 2024; 3:1040998.
PMID: 39355021
PMC: 11440952.
DOI: 10.3389/fnume.2023.1040998.
Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis.
Chamseddine I, Shah K, Lee H, Ehret F, Schuemann J, Bertolet A
Clin Cancer Res. 2024; 30(19):4424-4433.
PMID: 39106090
PMC: 11444871.
DOI: 10.1158/1078-0432.CCR-24-1215.
Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature.
Caglar Y, Buyuktepe M, Sayaci E, Dogan I, Bozkurt M, Peker E
Diagnostics (Basel). 2024; 14(14).
PMID: 39061688
PMC: 11275485.
DOI: 10.3390/diagnostics14141551.
Assessment of imaging risks for recurrence after stereotactic radiosurgery for brain metastases (IRRaS-BM).
Roh Y, Park J, Park S, Cho Y, Kim Y, Song S
BMC Cancer. 2024; 24(1):866.
PMID: 39026289
PMC: 11264672.
DOI: 10.1186/s12885-024-12636-5.
Prospective Study to Evaluate the Role of Dual Point Contrast-enhanced Magnetic Resonance Imaging in Differentiation of Brain Tumoral from Nontumoral Tissue: A Magnetic Resonance/PET Study.
Mangalore S, Pradeep G, Murthy V, Bairwa P, Kumar P, Saini J
Indian J Nucl Med. 2024; 39(2):87-97.
PMID: 38989312
PMC: 11232725.
DOI: 10.4103/ijnm.ijnm_103_23.
Brain Tumor Recurrence vs. Radiation Necrosis Classification and Patient Survivability Prediction.
Sadique M, Farzana W, Temtam A, Lappinen E, Vossough A, Iftekharuddin K
IEEE J Biomed Health Inform. 2024; 28(10):5685-5695.
PMID: 38875078
PMC: 11492206.
DOI: 10.1109/JBHI.2024.3406256.
Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors.
Cho N, Le V, Sanvito F, Oshima S, Harper J, Chun S
Neuro Oncol. 2024; 26(10):1823-1836.
PMID: 38808755
PMC: 11449060.
DOI: 10.1093/neuonc/noae097.
Narrow interval dual phase 18F-FDG PET/CT: A practical approach for distinguishing tumor recurrence from radiation necrosis in brain metastasis.
Aggarwal A, Aggarwal A, Prakash S, Vile D, Aggarwal A
Medicine (Baltimore). 2024; 103(18):e37789.
PMID: 38701250
PMC: 11062716.
DOI: 10.1097/MD.0000000000037789.
Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.
Ocana-Tienda B, Leon-Triana O, Perez-Beteta J, Jimenez-Sanchez J, Perez-Garcia V
PLoS Comput Biol. 2024; 20(1):e1011400.
PMID: 38289964
PMC: 10857744.
DOI: 10.1371/journal.pcbi.1011400.
Multiparametric Analysis Combining DSC-MR Perfusion and [18F]FET-PET is Superior to a Single Parameter Approach for Differentiation of Progressive Glioma from Radiation Necrosis.
Panholzer J, Malsiner-Walli G, Grun B, Kalev O, Sonnberger M, Pichler R
Clin Neuroradiol. 2023; 34(2):351-360.
PMID: 38157019
DOI: 10.1007/s00062-023-01372-1.
Can low-dose intravenous bevacizumab be as effective as high-dose bevacizumab for cerebral radiation necrosis?.
Gao M, Wang X, Wang X, Niu G, Liu X, Zhao S
Cancer Sci. 2023; 115(2):589-599.
PMID: 38146096
PMC: 10859604.
DOI: 10.1111/cas.16053.
Case Report: Radiation necrosis mimicking tumor progression in a patient with extranodal natural killer/T-cell lymphoma.
Chen B, Fan Y, Wang L, Zhang J, Xin D, Qiu X
Front Radiol. 2023; 3:1257565.
PMID: 37954919
PMC: 10634224.
DOI: 10.3389/fradi.2023.1257565.
Advanced Magnetic Resonance Imaging in the Evaluation of Treated Glioblastoma: A Pictorial Essay.
Martucci M, Russo R, Giordano C, Schiarelli C, DApolito G, Tuzza L
Cancers (Basel). 2023; 15(15).
PMID: 37568606
PMC: 10417432.
DOI: 10.3390/cancers15153790.
Radionecrosis mimicking pseudo‑progression in a patient with lung cancer and brain metastasis following the combination of anti‑PD‑1 therapy and stereotactic radiosurgery: A case report.
Ji X, Wang L, Tan Y, Shang Y, Huo R, Fang C
Oncol Lett. 2023; 26(2):361.
PMID: 37545620
PMC: 10398635.
DOI: 10.3892/ol.2023.13947.
Evaluation of the Diagnostic Performance of F18-Fluorodeoxyglucose-Positron Emission Tomography, Dynamic Susceptibility Contrast Perfusion, and Apparent Diffusion Coefficient in Differentiation between Recurrence of a High-grade Glioma and Radiation....
Peer S, Gopinath R, Saini J, Kumar P, Srinivas D, Nagaraj C
Indian J Nucl Med. 2023; 38(2):115-124.
PMID: 37456178
PMC: 10348492.
DOI: 10.4103/ijnm.ijnm_73_22.
Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
Calderon B, Vazquez L, Belkacemi M, Pourel N
Eur J Med Res. 2023; 28(1):233.
PMID: 37443046
PMC: 10339504.
DOI: 10.1186/s40001-023-01178-4.